GNOMvsFBTETF Comparison
Global X Genomics & Biotechnology ETF - USD (GNOM) belongs to the BioTech & Genomics segment. First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) is part of the US Health Care segment. Both ETFs have the same top 3 sector exposures: and Health Care. GNOM is less expensive with a Total Expense Ratio (TER) of 0.5%, versus 0.54% for FBT. GNOM is up 0.74% year-to-date (YTD) with -$602K in YTD flows. FBT performs worse with -0.93% YTD performance, and +$1.07B in YTD flows. Run a side-by-side ETF comparison of GNOM and FBT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
GNOM vs FBT performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM FBT | +7.67%+6.35% | -7.03%-6.86% | +0.74%-0.93% | +41.51%+29.41% | -6.56%+31.14% | -50.60%+24.73% |
| Flows | GNOM FBT | -$829K-$20M | +$1M+$101M | -$602K+$1.07B | -$14M+$1.08B | -$120M+$617M | +$1M+$289M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM FBT | +28.47%+23.37% | +27.16%+21.80% | +28.79%+20.22% | +33.22%+21.89% |
| Max drawdown | GNOM FBT | -16.08%-13.39% | -18.16%-14.27% | -46.50%-19.92% | -72.17%-29.98% |
| Max drawdown duration | GNOM FBT | 88d87d | 92d91d | 1075d237d | 1758d1243d |
GNOM | FBT | |
Last sale 4/27/2026 at 1:30 PM | $45.43 | $204.75 |
| Previous close 04/24/2026 | $45.97 | $204.04 |
| Consolidated volume 04/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GNOM | FBT | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GNOM | FBT | |
|---|---|---|
| Last price | $45.43 | $204.75 |
| 1D performance | -1.17% | +0.35% |
| AuM | $51.60 M | $2.31 B |
| E/R | 0.5% | 0.54% |
GNOM | FBT | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | Global X | First Trust |
| Benchmark | Solactive Genomics Index | NYSE Arca Biotechnology Index |
| N° of holdings | 45 | 28 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | June 19, 2006 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
